Dolby Laboratories (NYSE:DLB) Stock Rating Upgraded by Baird R W

Key Points

• Baird R W has upgraded Dolby Laboratories (NYSE:DLB) to a "hold" rating, reflecting a shift in the firm's outlook on the stock.
• Dolby recently reported quarterly earnings with $0.78 EPS, surpassing estimates and showing a revenue increase of 9.2% year-over-year.
• Institutional investors own 58.56% of Dolby's shares, indicating significant market interest, with various firms adjusting their positions in the company.

Dolby Laboratories (NYSE:DLB - Get Free Report) was upgraded by research analysts at Baird R W to a "hold" rating in a note issued to investors on Friday,Zacks.com reports.

A number of other equities research analysts also recently commented on the stock. Tigress Financial lifted their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a report on Friday, August 15th. Robert W. Baird assumed coverage on shares of Dolby Laboratories in a report on Friday, September 5th. They set a "neutral" rating and a $74.00 price target for the company. Wall Street Zen upgraded shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Finally, Rosenblatt Securities restated a "buy" rating and issued a $95.00 target price on shares of Dolby Laboratories in a report on Friday, August 1st. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Dolby Laboratories has a consensus rating of "Moderate Buy" and a consensus target price of $95.75.

Dolby Laboratories Trading Up 1.0%

Shares of NYSE DLB traded up $0.74 during midday trading on Friday, reaching $71.68. 71,739 shares of the stock were exchanged, compared to its average volume of 430,930. The company has a market capitalization of $6.87 billion, a P/E ratio of 26.25 and a beta of 0.93. Dolby Laboratories has a 52-week low of $68.24 and a 52-week high of $89.66. The stock has a 50 day moving average price of $73.88 and a 200-day moving average price of $75.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, topping analysts' consensus estimates of $0.72 by $0.06. The business had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current year.

Insider Buying and Selling

In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the transaction, the senior vice president directly owned 70,435 shares of the company's stock, valued at $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Yeaman sold 39,875 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total transaction of $2,983,447.50. Following the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $8,583,724.50. This trade represents a 25.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 99,366 shares of company stock worth $7,352,963. 38.39% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Alpine Bank Wealth Management acquired a new position in shares of Dolby Laboratories during the first quarter worth $25,000. MAI Capital Management lifted its position in shares of Dolby Laboratories by 87.1% during the first quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after purchasing an additional 162 shares in the last quarter. Cheviot Value Management LLC acquired a new position in shares of Dolby Laboratories during the first quarter worth $27,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Dolby Laboratories during the first quarter worth $29,000. Finally, Allworth Financial LP lifted its position in shares of Dolby Laboratories by 590.4% during the second quarter. Allworth Financial LP now owns 504 shares of the electronics maker's stock worth $37,000 after purchasing an additional 431 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.